Trimel Pharmaceuticals Announces Positive Phase II Results for Tefina™
May 28, 2014
Women treated with Tefina™ 0.6 mg reported a
statistically significant increase in orgasms versus placebo
TORONTO (May 28, 2014) – Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results...